Pages that link to "Q2552927"
Jump to navigation
Jump to search
The following pages link to cefepime (Q2552927):
Displayed 117 items.
- pneumonia (Q12192) (← links)
- staphylococcal infection (Q34879) (← links)
- sepsis (Q183134) (← links)
- urinary tract infection (Q221668) (← links)
- hyperthermia (Q242165) (← links)
- pyelonephritis (Q506652) (← links)
- neutropenia (Q1435822) (← links)
- ehrlichiosis (Q2845432) (← links)
- bacterial pneumonia (Q3776920) (← links)
- Escherichia coli infectious disease (Q4227886) (← links)
- infectious bone disease (Q6029216) (← links)
- Pseudomonas infection (Q7255052) (← links)
- Serratia infection (Q16935263) (← links)
- gram-negative bacterial infection (Q19597369) (← links)
- (Q5673490) (redirect page) (← links)
- E-cefepime (Q27294816) (← links)
- Efficacy and safety of cefepime: a systematic review and meta-analysis (Q28298744) (← links)
- Acute neurological deficits caused by cefipime: a case report and review of literature. (Q31090998) (← links)
- Extension of resistance to cefepime and cefpirome associated to a six amino acid deletion in the H-10 helix of the cephalosporinase of an Enterobacter cloacae clinical isolate (Q31942619) (← links)
- Population pharmacokinetics of cefepime in the neonate (Q33883677) (← links)
- SHV-type extended-spectrum beta-lactamase production is associated with Reduced cefepime susceptibility in Enterobacter cloacae (Q34073514) (← links)
- Cefepime microbiologic profile and update (Q34219993) (← links)
- Pharmacodynamic considerations in the treatment of moderate to severe pseudomonal infections with cefepime (Q34543630) (← links)
- Is there a rationale for the continuous infusion of cefepime? A multidisciplinary approach (Q35171850) (← links)
- Acquisition of rectal colonization by vancomycin-resistant Enterococcus among intensive care unit patients treated with piperacillin-tazobactam versus those receiving cefepime-containing antibiotic regimens (Q36425019) (← links)
- Phenotypic detection of extended-spectrum beta-lactamase production in Enterobacteriaceae: review and bench guide. (Q37043607) (← links)
- Cefepime: a reappraisal in an era of increasing antimicrobial resistance (Q37079350) (← links)
- Cefepime and its role in pediatric infections (Q37232701) (← links)
- Selective immediate hypersensitivity to cefepime. (Q40456882) (← links)
- Antimicrobial susceptibility survey of Pseudomonas aeruginosa strains isolated from clinical sources (Q40490244) (← links)
- Treatment of febrile neutropenia with cefepime monotherapy (Q40604346) (← links)
- Randomized comparison of cefepime versus ceftazidime monotherapy for fever and neutropenia in children with solid tumors (Q40605985) (← links)
- Susceptibility of bacterial isolates to cefepime in comparison to other broad spectrum antimicrobial agents at a tertiary care center in Lebanon (Q40651129) (← links)
- Cross-reactivity in β-Lactam Allergy (Q41987583) (← links)
- Alteration of pore properties of Escherichia coli OmpF induced by mutation of key residues in anti-loop 3 region (Q42124562) (← links)
- Multicentre study of the in vitro activity of cefepime, a broad-spectrum cephalosporin, compared to other broad-spectrum agents (Q43560987) (← links)
- Pancreatic concentrations of cefepime (Q43592317) (← links)
- Cefepime versus vancomycin plus netilmicin therapy for continuous ambulatory peritoneal dialysis-associated peritonitis (Q43657253) (← links)
- Comparison of cefepime pharmacokinetics in neonatal foals and adult dogs. (Q43666169) (← links)
- Experience with maxipime in neurosurgical clinic (Q44662653) (← links)
- Synthesis and biological activities of diflunisal hydrazide-hydrazones (Q44671495) (← links)
- Antimicrobial activity of cefepime tested against ceftazidime-resistant Gram-negative clinical strains from North American Hospitals: report from the SENTRY Antimicrobial Surveillance Program (1998-2004). (Q44764127) (← links)
- Stability of cefepime in icodextrin peritoneal dialysis solution (Q45114992) (← links)
- Influence of plasma exchange on the disposition of the fourth generation cephalosporin cefepime. (Q46079245) (← links)
- Participation of metallo-beta-lactamases in resistance to imipenem and meropenem in clinical strains of Pseudomonas aeruginosa and Acinetobacter spp (Q46419234) (← links)
- Cefepime-induced encephalopathy: clinical and electroencephalographic features in seven patients (Q46437411) (← links)
- Renal failure is a risk factor for cefepime-induced encephalopathy. (Q46465508) (← links)
- Cefepime and continuous renal replacement therapy (CRRT): in vitro permeability of two CRRT membranes and pharmacokinetics in four critically ill patients (Q46566491) (← links)
- Maxipime (Q47521328) (← links)
- Contact urticaria syndrome with IgE antibody against a cefotiam-unique structure, evoked by nonapparent exposure to cefotiam. (Q53701678) (← links)
- Comparisons of parenteral broad-spectrum cephalosporins tested against bacterial isolates from pediatric patients: report from the SENTRY Antimicrobial Surveillance Program (1998-2004). (Q54457092) (← links)
- A Pharmacokinetic Study of Cefepime After Administration Into Dialysate in Patients With Continuous Ambulatory Peritoneal Dialysis (CAPD) Peritonitis (Q61917381) (← links)
- Safety and Efficacy Study of Cefepime-AAI101 in the Treatment of Complicated Urinary Tract Infections (Q62054422) (← links)
- Investigation of AAI101 Safety, Tolerability & PK in Healthy Volunteers (Q62054602) (← links)
- Cefepime/AAI101 Phase 2 Study in Hospitalized Adults With cUTI (Q62054970) (← links)
- Lung Pharmacokinetics (PK) in Epithelial Lining Fluid (ELF) (Q62054990) (← links)
- Pharmacokinetics of Cefepime and AAI101 in Subjects With Renal Insufficiency and Healthy Subjects (Q62054992) (← links)
- Safety and Efficacy Study of Ftortiazinon in the Treatment of Patients With Complicated Urinary Tract Infections Caused by P. Aeruginosa (Q62063081) (← links)
- Synthetic Approach to Gain Insight into Antigenic Determinants of Cephalosporins: In Vitro Studies of Chemical Structure−IgE Molecular Recognition Relationships (Q62129951) (← links)
- Comparative Study To Determine The Efficacy, Safety, And Tolerability Of Ceftolozane-Tazobactam (Q62809434) (← links)
- Study of Cefepime-tazobactam (FEP-TAZ) in Complicated Urinary Tract Infection (cUTI) or Acute Pyelonephritis (AP) (Q63395045) (← links)
- Safety and Pharmacokinetics of VNRX-5133 in the Epithelial Lining Fluid of Healthy Adult Subjects (Q63577868) (← links)
- A Safety and Tolerability Study of Doripenem Compared With Cefepime in Hospitalized Children With Bacterial Pneumonia (Q63833153) (← links)
- A Safety and Tolerability Study of Doripenem Compared With Cefepime in Children Hospitalized With Complicated Urinary Tract Infections (Q63833156) (← links)
- Study on Reduced Antibiotic Treatment vs Broad Spectrum Betalactam in Patients With Bacteremia by Enterobacteriaceae (Q64139504) (← links)
- Pharmacokinetics and Pharmacodynamics of Extended-Infusion Cefepime in Continuous Renal Replacement Therapy (Q64172297) (← links)
- Safety and Efficacy Study of Cefepime/VNRX-5133 in Patients With Complicated Urinary Tract Infections (Q64187644) (← links)
- Patients Response to Early Switch To Oral:Osteomyelitis Study (Q64220007) (← links)
- An Efficacy and Safety of Flomoxef Versus Cefepime in the Treatment of Participants With Urinary Tract Infections (Q64598967) (← links)
- A Study Comparing Continuous Infusion Antibiotics to Standard Treatment for Lung Infections in Cystic Fibrosis (Q64642378) (← links)
- Prolonged or Standard Infusion of Cefepime Hydrochloride in Treating Patients With Febrile Neutropenia (Q64647122) (← links)
- Efficacy of Cefepime Continuous Infusion Versus an Intermittent Dosing Regimen (Q64724566) (← links)
- Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of WCK 5107 Alone and in Combination With Cefepime (Q65335174) (← links)
- Evaluation of Safety, Pharmacokinetics and Efficacy of Ceftazidime and Avibactam (CAZ-AVI ) Compared With Cefepime in Children From 3 Months to Less Than 18 Years of Age With Complicated Urinary Tract Infections (cUTIs) (Q65344129) (← links)
- Efficacy of Oral Antibiotic Therapy Compared to Intravenous Antibiotic Therapy for Osteomyelitis (Q65354709) (← links)
- Antibiotic Treatment Duration for Non-Surgically-Treated Diabetic Foot Osteomyelitis (Q65360370) (← links)
- Imipenem Versus Cefepime in Spontaneous Bacterial Peritonitis and to Evaluate the Risk Factors for Treatment Failure (Q65364351) (← links)
- An Open-label, Randomized, and Comparative Study to Evaluate the Efficacy and Safety of Cefoperazone/Sulbactam in Comparison to Cefepime for the Treatment of Hospital-acquired Pneumonia and Healthcare-associated Pneumonia (Q65375674) (← links)
- A Study of Ceftobiprole in Patients With Fever and Neutropenia. (Q65381250) (← links)
- A Single-dose Study to Investigate the Pharmacokinetics of Intravenous FEP-TAZ in Patients With Renal Impairment (Q65394189) (← links)
- Target-controlled Infusion Model for Cefepime (Q65395811) (← links)
- MED Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Intravenous WCK 5222 (Zidebactam and Cefepime) in Healthy Volunteers (Q65395827) (← links)
- Individualized Cefepime Dosing Study (Q65399681) (← links)
- Cefepime vs. Ceftriaxone to Treat Nursing Home-Acquired Pneumonia (Q65475055) (← links)
- Cefepime Pharmacokinetics in Liver Transplant Recipients in an Intensive Care Unit (Q66026331) (← links)
- Pharmacodynamic Parameters of Two Different Doses of Cefepime (Q66026365) (← links)
- Comparing Ciprofloxacin (CPFX) With Cefepime (CFPM) in Febrile Neutropenic Patients With Hematologic Diseases (Q66029022) (← links)
- Levofloxacin Compared With Cefepime in Treating Cancer Patients With Fever and Neutropenia (Q66034433) (← links)
- Study Comparing the Safety and Efficacy of Piperacillin/Tazobactam to Cefepime in Patients With Hematologic Malignancy or Lymphoma (Q66039853) (← links)
- Single Dose Cefepime Versus Cefuroxime Plus Metronidazole as a Prophylactic Antibiotic During Emergency Intrapartum Cesarean Section (Q66063073) (← links)
- Choosing the Best Antibiotic to Protect Friendly Gut Bacteria During the Course of Stem Cell Transplant (Q66073407) (← links)
- To Investigate The Pharmacokinetics Of Intravenous WCK 5222 (FEP-ZID) In Patients With Renal Impairment (Q66079846) (← links)
- Comparing Cefepime Versus Cefazolin Plus Ceftazidime for CAPD-associated Peritonitis (Q66083825) (← links)
- PK/PD of Extended-infusion Meropenem, Piperacillin-tazobactam and Cefepime in the Early Phase of Septic Shock (Q66398804) (← links)
- Comparative Study of Ceftazidime-Avibactam Versus Standard of Care as Therapy in Febrile Neutropenic Adults With Cancer (Q66546579) (← links)
- Prolonged Infusion Cefepime and Nosocomial Infections (Q67127223) (← links)
- Evaluation of the Cephalosporins, Cefepime, Cefpirome and Ceftazidime, against Clinical Isolates of Imipenem-Resistant Pseudomonas aeruginosa (Q73205788) (← links)
- Severe but reversible encephalopathy associated with cefepime (Q73471530) (← links)
- Cefepime vs Ceftazidime as Empirical Therapy for Neutropenic Fever (Q79111450) (← links)
- Development and in-house validation of a microbiological assay for determination of cefepime in injectable preparations (Q79245407) (← links)
- Cefepime restriction improves gram-negative overall resistance patterns in neonatal intensive care unit (Q80599996) (← links)
- Effect of antibiotic heterogeneity on the development of infections with antibiotic-resistant gram-negative organisms in a non-intensive care unit surgical ward (Q83357901) (← links)
- Efficacy of Extended Infusion of β-lactam Antibiotics for the Treatment of Febrile Neutropenia in Hematologic Patients (Q83806634) (← links)
- Association of Cefepime Trough Levels With Clinical Efficacy and Neurotoxicity in Patients With Febrile Neutropenia (Q86297816) (← links)
- Antibiotics Continuous Infusion at Home (Q107213797) (← links)
- Early Versus Late Stopping of Antibiotics in Children With Cancer and High-risk Febrile Neutropenia (Q107972985) (← links)
- (Q113348643) (redirect page) (← links)
- PHASE II SINGLE-CENTER, RANDOMIZED, OPEN-LABEL, PROSPECTIVE, STUDY TO DETERMINE THE IMPACT OF SERIAL PROCALCITONIN (Q113919489) (← links)
- Postoperative Antibiotic Management Duration Following Surgery for Intravenous Drug Abuse (IVDA) Endocarditis (OPTIMAL) (Q113922144) (← links)
- cefepime/enmetazobactam (Q124570890) (← links)
- User:Mr. Ibrahem/P12081 (← links | edit)
- User:DeltaBot/fixClaims/maintenance/P715format (← links | edit)
- Wikidata:Database reports/Constraint violations/P2176 (← links | edit)
- Wikidata:Database reports/Constraint violations/P2175 (← links | edit)
- Wikidata:Database reports/Constraint violations/P2275 (← links | edit)
- Wikidata:Database reports/Constraint violations/P2892 (← links | edit)
- Wikidata:Database reports/Constraint violations/P12081 (← links | edit)